27.6 C
Vientiane
Monday, September 22, 2025
spot_img
Home Blog Page 63

Kolmar Korea Advances ‘Clean Beauty’ with Breakthroughs from Eco-Friendly Packaging to R&D

  • Sweeps global awards with eco-friendly packaging innovations, including paper tube, paper stick, and paper pack
  • Ranked No. 125 on TIME‘s “World’s Best Companies for Sustainable Growth 2025,” the only K-Beauty company on the list

SEOUL, South Korea, Sept. 15, 2025 /PRNewswire/ — Kolmar Korea, a global cosmetics ODM company, is strengthening its commitment to “clean beauty.” From eco-friendly packaging to raw material and formulation development, as well as sustainable production processes, the company is enhancing its ESG management to secure differentiated competitiveness in the global market.

Kolmar Korea’s eco-friendly packaging innovations—paper tube (left), paper stick, and one-hand pump paper pack
Kolmar Korea’s eco-friendly packaging innovations—paper tube (left), paper stick, and one-hand pump paper pack

The company’s eco-friendly packaging has garnered the most attention. In 2020, Kolmar Korea introduced the paper tube, the industry’s first eco-friendly container to successfully achieve commercialization. It reduced plastic usage by 80%, is designed for easy separation of paper and plastic, and is durable enough to withstand over 50 kg of weight. In 2023, it developed the paper stick with mineral paper, cutting plastic use by 86%. Designed to peel away layers of paper, the stick allows consumers to use the entire product without waste, balancing sustainability with practicality. This April, the company unveiled the one-hand pump paper pack, a milk-carton-inspired design that integrates a pump function. Made from 100% recyclable materials, it provides both user convenience and the eco-friendly attributes global consumers demand.

These innovations have earned international recognition. The paper tube and paper stick achieved a “grand slam” in design by winning the world’s top three design awards—IDEA, iF Design Award, and Red Dot Design Award. The one-hand pump paper pack also won a Red Dot Design Award this year, further validating the global competitiveness of Kolmar Korea’s eco-friendly packaging.

Beyond packaging, Kolmar Korea is strengthening clean beauty in raw materials and formulations. In 2022, the company developed an eco-friendly extraction method using sunflower, lingonberry, and starflower that reduced carbon emissions by 83% while boosting active ingredient efficacy by 870%. Applied in its 2023 clean beauty sunscreen, this innovation earned Korea’s Ministry of Environment “Green Technology Product” certification. That same year, Kolmar Korea replaced microplastics in color cosmetics with natural silica, a mineral known for pore care and sebum control, improving texture and stability while advancing both functionality and sustainability.

Kolmar Korea is also driving low-carbon and eco-friendly manufacturing. The company joined the K-RE100 initiative in 2022, pledging 100% renewable energy use by 2050. At its key Sejong plant, expanded solar facilities in 2023 cut approximately 143 tons of CO₂ emissions. The company also operates a dedicated division targeting “zero landfill waste,” reducing landfill rates and boosting recycling through systematic sustainability management.

These wide-ranging efforts have gained global recognition. In 2024, TIME magazine ranked Kolmar Korea No. 125 on its “World’s Best Companies for Sustainable Growth 2025” list, the only K-Beauty company included, affirming its leadership in eco-friendly practices in the global market.

A Kolmar Korea spokesperson said, “Developing eco-friendly technologies is not a short-term achievement but a core business strategy to enhance the sustainability of the entire industry. We will continue to demonstrate leadership as a company driving sustainable growth in the global beauty sector.”

About Kolmar Korea
Kolmar Korea is a global cosmetics ODM headquartered in Seoul, South Korea. The company is recognized for innovation in formulation, packaging, and sustainable manufacturing, partnering with leading beauty brands worldwide. Through ESG-driven management and continuous R&D, Kolmar Korea advances clean beauty and eco-friendly solutions to shape a more sustainable future for the global beauty industry.

Media Contact
Kolmar Holdings
Jang-Woo Lee
jay.lee@kolmar.co.kr

SI GROUP TO SHOWCASE SUSTAINABLE ADDITIVE INNOVATIONS AT K 2025

Industry Leader Presents Advanced Solutions for Plastics and Rubber

THE WOODLANDS, Texas, Sept. 15, 2025 /PRNewswire/ — SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals, and chemical intermediates, will showcase its portfolio of innovative additive technologies at the K 2025 exhibition in Düsseldorf, Germany, October 8-15, 2025. Meet SI Group during K 2025 at Hall 6, Booth B08.

Daily technical presentations will be hosted at the SI Group booth, highlighting the company’s latest solutions that enhance performance and sustainability across a variety of plastics applications. Technical experts will present their latest solutions in recycled polypropylene, PFAS-free additives, and Arvin-free technologies designed for automotive, packaging, and consumer applications. K 2025 visitors can register to attend the technical talks at Eventbrite.

Featured products at SI Group’s booth will highlight the company’s commitment to driving forward-thinking solutions that support sustainable practices within the plastic and rubber industries. Products include:

  • WESTON 705 – A next-generation, nonylphenol-free liquid phosphite antioxidant for plastics and elastomers. Approved for food contact in more than 50 countries, it is a best-in-class stabilizer for polyethylene blown films. 
  • LOWINOX 1790 – High-performance hindered phenolic antioxidant designed to be more effective at preventing spandex oxidation and degradation than commonly used HN-150/LOWINOX GP45 blend. With an enhanced safety and environmental profile, LOWINOX 1790 does not generate NDMA or any known carcinogens.
  • LOWINOX™ TBM6 – Hindered thiophenol antioxidant that is highly pure and clean, specifically designed for high voltage cable insulation.
  • NAUGARD BIO-XL – An accelerator with over 95% biocarbon-based content for sulfur curing of natural and synthetic rubbers. NAUGARD BIO-XL does not release harmful nitrosamines as listed in TRGS552.
  • NAUGATAC 1068-ULM – SI Group’s latest tackifier offers a reduced SVHC-content option, enhances tack retention in a wide range of elastomers, including tire compounds, treads, hoses, belts, and other rubber articles, and delivers performance equal to or better than conventional tackifiers.

These products will be showcased through an interactive booth display designed to demonstrate their technical benefits and applications.

“Sustainability and performance are at the center of everything we do,” said Robert Kaiser, VP Polymer Solutions and Managing Director at SI Group. “Our presence at K 2025 underscores our commitment to advancing circular and responsible solutions. We remain focused on meeting regulatory requirements while ensuring our additive platforms, like EVERCYCLE™ and NAUGARD BIO-XL, continue to deliver the reliable, high-performance results our customers expect.”

To explore SI Group’s full portfolio of performance additives and solutions for the plastics and rubber industries, visit www.siigroup.com.

About SI Group
SI Group is a global leader in the innovative technology of performance additives, process solutions, active pharmaceutical ingredients, and chemical intermediates. SI Group solutions are essential to enhancing the quality and performance of countless industrial and consumer goods within plastics, rubber & adhesives, fuels & lubricants, oilfield, and pharmaceutical industries. SI Group’s global manufacturing footprint includes 19 facilities on three continents, serving customers in 80 countries with approximately 1,600 employees worldwide. In 2025, SI Group received a bronze award for corporate social responsibility by EcoVadis and is ranked among the top 35 percent of the more than 150,000 companies worldwide. SI Group innovates and drives change to create value with a passion for safety, chemistry, sustainability, and extraordinary results. Learn more at www.siigroup.com

Press Release
Media Contact: Joseph Grande
ph: + 1.413.684.2463
joe@jgrandecommunications.com

 

Univers Named a Leader in 2025 Gartner® Magic Quadrant™ for Global Industrial IoT Platforms

SINGAPORE, Sept. 15, 2025 /PRNewswire/ — Univers, a global leader in AI for Energy, today announced that it has been positioned as a Leader in the 2025 Gartner Magic Quadrant for Global Industrial IoT Platforms.

Univers Named a Leader in 2025 Gartner® Magic Quadrant™ for Global Industrial IoT Platforms
Univers Named a Leader in 2025 Gartner® Magic Quadrant™ for Global Industrial IoT Platforms

The Gartner assessment recognizes Univers for its EnOS™ platform for its ability to execute and its completeness of vision.

In just seven years, Univers has built a global AI-first platform that now connects 365 million devices and manages 845 GW of renewable energy — nearly one-fifth of the world’s total capacity.

“Being recognized as a Leader in the Magic Quadrant so early in our journey is a proud moment for Univers.  This recognition underscores the company’s ability to innovate at speed and deliver impact at scale,” said Michael Ding, Global Executive Director, Univers. “It affirms that that an AI-first approach to energy and industrial IoT delivers tangible business results and sustainability outcomes for customers worldwide. We believe that this recognition validates our vision and fuels our commitment to help industries decarbonize and innovate at scale.”

Rather than siloed tools, EnOS™ offers a unified platform where industries can move from automation to autonomous intelligence. With applied AI, enterprises can detect risks before they escalate, balance energy flows across global operations, and accelerate the transition to low-carbon systems.

Univers’ rapid rise also reflects its ecosystem strength: global integrators are embedding EnOS™ into large-scale deployments, while technology partners extend AI capabilities into new industrial and energy use cases.

“Looking ahead, Univers remains focused on pushing the boundaries of AI for Energy, advancing from monitoring and optimization to fully autonomous operations and empowering industries worldwide to achieve resilience, efficiency, and sustainability at scale,” added Michael.

Gartner, Magic Quadrant for Global Industrial IoT Platforms, By Scot Kim, Sudip Pattanayak et al., 8 September 2025

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, Magic Quadrant is a registered trademark of Gartner, Inc. and/or its affiliates and is used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Univers

Univers is a global leader for AI in Energy.

Univers’ EnOS™ platform empowers enterprises across industries to solve complex energy challenges with intelligent, data-driven insights.

With 365 million devices connected, 845GW of renewable energy managed, and a global network of 800+ customers, we are the only global technology partner offering a truly comprehensive, end-to-end energy management solution, supporting enterprises at every stage of their energy transition journey.

For more information, please visit univers.com.

MINT Incorporation Limited Announces the Launch of New Subsidiary, Axonex Intelligence Limited, Expanding into Smart Facility Management Solutions


HONG KONG SAR – Media OutReach Newswire – 15 September 2025 – MINT Incorporation Limited (NASDAQ: MIMI) (“MINT” or the “Company”), a leading Hong Kong-based provider of integrated interior design and fit out works, today announced the official launch of its wholly owned subsidiary, Axonex Intelligence Limited (“Axonex”), a company incorporated with limited liability under the laws of Hong Kong, marking MINT’s expansion into the technology realm with the fast-growing smart facility management sector. Building on this foundation, MINT is extending its expertise to harness robotics, IoT, and AI technologies to enhance the way properties are managed and experienced.

Axonex provides total solutions for smart facility management, integrating advanced technologies to improve efficiency, safety, and user experience across different property types. Its key capabilities include:

  • Robotic solutions to automate routine facility management tasks, improve efficiency, and reduce manpower needs.
  • Object identification and human posture recognition for enhanced security and operational monitoring.
  • Digital twin solutions enabling real-time visualization and management of facilities.
  • AI-powered analytics to optimize maintenance, space utilization, and resource allocation.

Axonex is set to serve a diverse range of clients, including shopping malls, government premises, residential complexes, and warehouses. By leveraging its design background and new technological focus, Axonex aims to provide a holistic approach to property and facility management.

To support its solutions, Axonex is collaborating with technology partners such as AIMO and Sharp Peak, ensuring strong hardware and software integration.

With this strategic move, MINT reaffirms its commitment to innovation and its mission to provide comprehensive solutions that blend design excellence with cutting-edge technology.

Forward Looking Statements

This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include the risks and uncertainties described in the Company’s annual report on Form 20-F for the year ended March 31, 2025. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

Hashtag: #MINTIncorporation #AxonexIntelligence

The issuer is solely responsible for the content of this announcement.

About MINT Incorporation Limited

The Company is a Hong Kong-based interior design and fit out works provider, with a strategic focus on providing integrated and industry-specific interior design and fit out works for commercial properties. The Company’s work encompasses offices of different industries and various kinds of retail stores with a view to reflect its customers’ corporate values and conceptualizing our customers’ brands. The Company’s commercial projects cover internationally renowned retail stores, F&B outlet chains and offices and other premises of a premier charitable organization in Hong Kong. The Company also provides integrated interior design and fit out works for luxury residential properties in order to enhance both the aesthetics and functionality of the interior space.

About Axonex Intelligence Limited
Axonex Intelligence Limited, a company incorporated with limited liability under the laws of Hong Kong and subsidiary of MINT Incorporation Limited, delivers comprehensive solutions for smart facility management through the integration of robotics, IoT devices, and AI-powered analytics. By enabling real-time monitoring, predictive insights, and digital twin technologies, Axonex helps clients optimize operations and elevate user experiences across diverse property types. Guided by its vision of being a one-stop partner, Axonex is committed to helping organizations seamlessly integrate cutting-edge technologies into their daily operations.

Sercomm Showcases Next-Gen RDK Video Accelerator STB Based on Broadcom BCM74116 at the RDK Global Summit 2025

AMSTERDAM, Sept. 15, 2025 /PRNewswire/ — At the RDK Global Summit, Sercomm Corporation (TWSE: 5388), a leading global provider of entertainment and broadband equipment, today introduced its newest RDK Video Accelerator based on the latest Broadcom BCM74116 integrated System on Chip (SoC). This new state-of-the-art STB will also use the latest RDK7 software release. 

RDK is an open-source software platform that standardizes core functions used in video and broadband devices. RDK enables service providers to control their device diagnostics data, business models, and apps to improve the customer experience and drive business results. The new Sercomm STB platform is designed to accelerate integration with operator user interfaces and video services, enabling speedier product launches, robust long-term support, and pre-integrated with several premium streaming apps. 

Sercomm’s RDK-7 Streamer with NPU
Sercomm’s RDK-7 Streamer with NPU

“Sercomm’s market innovation continues with the launch of their new RDK7-ready set-top box,” said Jason Briggs, President and GM of RDK. “As a Preferred Member of the RDK community, we’re very proud to see Sercomm’s ongoing commitment to serve our expansive operator community across the globe.”

“We are proud to announce our latest RDK Video Accelerator together with our partners Broadcom and RDK,” said Amir Mobini, Vice President of Global Product Marketing at Sercomm. “As a vertically-integrated, globally diverse OEM with a strong record as a leading shipper of RDK streaming set-top boxes worldwide, Sercomm stands ready to support operators who are looking for a set-top box platform solution based on the latest RDK architecture that can be quickly launched and tightly integrated into their subscriber services and offerings. This platform is one of the first of its kind to offer integrated edge AI powering a new wave of monetization opportunities for our operator partners.”

About Sercomm

Founded in 1992, Sercomm (TWSE: 5388) is a global leader in providing integrated networking and telecom solutions. Partnering with the world’s top service providers, system integrators, and leading technology companies, Sercomm’s expertise in designing and manufacturing innovative, customized solutions makes embedding connectivity more accessible across the globe.

For more information, please visit https://www.sercomm.com/

The Korea Industry Daily: Industrial AI EXPO 2025 Concludes, Marking Milestone in Korea’s AI-Driven Industrial Transformation

SEOUL, South Korea, Sept. 15, 2025 /PRNewswire/ — The first-ever Industrial AI EXPO wrapped up at COEX Magok Convention Center after a three-day run from September 3 to 5, positioning itself as a key platform for accelerating the adoption of artificial intelligence across Korea’s industrial sectors.

The first-ever Industrial AI EXPO wrapped up at COEX Magok Convention Center after a three-day run from September 3 to 5, positioning itself as a key platform for accelerating the adoption of artificial intelligence across Korea’s industrial sectors.
The first-ever Industrial AI EXPO wrapped up at COEX Magok Convention Center after a three-day run from September 3 to 5, positioning itself as a key platform for accelerating the adoption of artificial intelligence across Korea’s industrial sectors.

The exhibition brought together 133 companies across 320 booths, unveiling a wide range of industrial AI equipment and solutions for the first time. The event opened with a series of high-level activities, including a memorandum of understanding (MOU) on building a data-sharing ecosystem for manufacturing and a Minister of Trade, Industry and Energy Award ceremony, recognizing 25 individuals and organizations for their contributions to industrial digital transformation and AI utilization.

Government officials and industry leaders—including executives from HD Hyundai, LG CNS, Microsoft Korea, Dassault Systèmes, HP Korea, Salesforce, and major domestic institutions—attended the opening ceremony, underscoring collective commitment to advancing industrial AI.

Vertical AI Showcases and Technology Debuts

The expo highlighted 12 key industrial AI task areas, covering market forecasting, supply chain optimization, process control, predictive maintenance, safety, workforce training, and cybersecurity. Exhibitors demonstrated how AI can improve efficiency and resilience in manufacturing and beyond.

Notably, HD Hyundai shared AI adoption cases from shipbuilding and construction equipment, while debuting its broader AIX (AI Transformation) strategy. Robotics, on-device AI, and physical AI technologies also made their first appearances, reflecting the next phase of industrial automation.

Global players including Microsoft, Dassault Systèmes, HP, NVIDIA (with domestic partner Leaders Systems), and Salesforce joined with Korean partners to showcase AI-driven innovations in manufacturing, customer management, and design—expanding both domestic B2B pipelines and global collaboration opportunities.

Conferences, Forums, and Business Networking

Beyond the exhibition floor, the event hosted a series of programs designed to strengthen the industrial AI ecosystem:

  • Industrial AI Conference – case studies and business models from leading corporations
  • AI-Tech Seminars – new technology launches and commercialization success stories
  • 1:1 Business Matching – connecting suppliers with demand-side enterprises
  • Startup IR and Investment Networking – pitches, mentoring, and investor sessions
  • Industrial AI International Certification Forum – discussions on reliability, safety, and standards with global stakeholders

Visitors also participated in guided docent tours, LG Science Park programs, and interactive events that highlighted industrial AI use cases across physical AI, manufacturing AI, and AI agent domains.

Building Korea’s Industrial AI Ecosystem

Lee Gil-seon, Executive Managing Director of the Korea Smart Manufacturing Industry Association, emphasized:

“As the country’s first vertical AI exhibition, Industrial AI EXPO presented a wealth of successful application cases. By serving as a matching platform between supply and demand, the expo will accelerate the adoption of AI across industries, strengthen Korea’s industrial AI ecosystem, and enhance global competitiveness.”

The successful conclusion of the Industrial AI EXPO 2025 underscored Korea’s determination to leverage artificial intelligence not only as a technological tool but as a transformative driver of industrial innovation.

Biostar Pharma Successively Achieved First Patient Dosing for Two Phase II/III Multiregional Clinical Trials of Utidelone Capsule (UTD2)

SAN FRANCISCO, Sept. 15, 2025 /PRNewswire/ — Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (“Biostar”, Stock Code: 2563.HK) which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of innovative oncology drugs, is pleased to announce that the first patients have been dosed for two phase II/III multiregional clinical trials (MRCT) of “Utidelone Capsule (UTD2) first-line treatment for locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma” (NCT06841679) and “UTD2 treatment for platinum-resistant advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer” (NCT07044349) on September 11, 2025 and September 12, 2025, respectively.

Utidelone has demonstrated excellent clinical data in gastric cancer: in a completed Phase II study of Utidelone Injection (UTD1) combined with PD-1 inhibitor and oxaliplatin for the first-line treatment of unresectable locally advanced or recurrent/metastatic HER2-negative gastric cancer, 23 patients had completed efficacy evaluation. Among them, 15 achieved partial response (PR) and 8 achieved stable disease (SD), resulting in a 65.2% objective response rate (ORR) and 100% clinical benefit rate (CBR). The median progression-free survival (mPFS) was 6.1 months. The combination regimen was generally well-tolerated. Most treatment-related adverse events (TRAEs) were Grade 1-2, reversible, and manageable. The longest treatment duration received by a patient was 22 cycles [1]. Consequently, Utidelone was granted an Orphan Drug Designation by the U.S. FDA for the treatment of advanced gastric cancer.

Besides gastric cancer, Utidelone has also shown considerable potential for treating ovarian cancer in previous clinical studies. A US Phase I clinical study of UTD2 as a monotherapy for advanced solid tumors had 12 evaluable patients, including one ovarian cancer patient with a complete response (CR) and another with PR, who had previously undergone 7 and 9 lines of therapy, respectively [2]. A Phase II clinical study of UTD1 as monotherapy for the treatment of advanced solid tumors had 10 evaluable patients in advanced ovarian cancer cohort, among them there were 1 PR and 3 SD.

Compared to taxanes, which are difficult for oral formulation development, Utidelone is not susceptible to P-glycoprotein thus cannot be pumped out of the cancer cell by P-glycoprotein and has the advantage for higher oral bioavailability and lower risk of developing cross-resistance. By utilizing its technology platform, Biostar developed Utidelone Capsule, and its efficacy and safety have been confirmed in both US and China’s studies. Utidelone Capsule will significantly improve the convenience of administration, compliance of patients, decrease in treatment cost and ease of combination therapy with other oral anti-cancer drugs, and more suitable for adjuvant or maintenance therapy. Beyond gastric and ovarian cancers, Biostar is actively planning and advancing multiple clinical studies to expand UTD2’s indications, including breast cancer adjuvant intensification therapy, pancreatic cancer, esophageal cancer, colorectal cancer, and so on.

About NCT06841679 Study

This study is a multi-national, open-label, randomized phase II/III clinical study of UTD2 combined with standard of care to evaluate the efficacy and safety in first-line patients with locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma, untreated with systemic treatment in the advanced setting. For the Phase II part, 78 subjects are planned to be enrolled in China, US, Europe and Japan. Its primary objectives are to evaluate the safety, efficacy, and pharmacokinetic profile of UTD2 in combination therapy. The Phase III part plans to enroll 700 subjects across multiple countries/regions. The primary endpoint is overall survival (OS), with secondary endpoints including PFS, ORR, and safety.

About NCT07044349 Study

This study is a multi-national, open-label, randomized Phase II/III clinical trial of UTD2 for the treatment of patients with platinum-resistant advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer. The Phase II part plans to enroll approximately 84 subjects. Its primary objective is to evaluate the safety, efficacy, and pharmacokinetic (PK) characteristics of UTD2 under different dosing regimens in the target patient population and to recommend a dose for Phase III. The Phase III part plans to enroll 480 subjects and is planned to be conducted in multiple countries and regions worldwide. Its primary objective is to evaluate the efficacy and safety of UTD2 compared to the investigator’s choice of standard treatment in the target patient population. The primary endpoint is PFS, with secondary endpoints including OS, ORR, and others.

About Utidelone

Utidelone is a new-generation genetically engineered microtubule inhibitor, and has similar mechanism of action with that of taxanes while demonstrating multiple advantages, including better anti-tumor activity, broader anti-tumor spectrum, better safety profile with very low hematologic toxicity, effective against multidrug-resistant tumors, less prone to developing drug resistance, capability of crossing the blood-brain barrier to prevent and treat brain tumors, and high oral bioavailability. Biostar has developed two formulations of Utidelone: injection (UTD1) and capsule (UTD2). UTD1 has been launched in China in 2021 for the treatment of metastatic breast cancer (MBC), who have progressed after at least one anthracycline- or taxane-containing chemotherapy regimen. The phase III study data showed that UTD1 plus capecitabine achieved both PFS and OS benefits versus capecitabine for heavily pretreated MBC patients, and the results were orally presented twice at ASCO annual meetings and published in prestigious journals [3-4].

About Biostar

Biostar is an integrated biopharma company focusing on the development of innovative anti-cancer drugs utilizing its synthetic biology R&D platform. The company is listed on the Hong Kong Stock Exchange (HK 2563) in 2024. We are actively selecting reliable global partners through out-licensing or co-development of Utidelone assets. We believe that our strong capabilities of R&D and manufacturing, coupled with our enriched commercial expertise, make us the preferred partner for global biopharmaceutical companies who share our goal of bringing innovative anti-cancer products to patients around the world. For additional information on partnering with Biostar, please contact our business development team at bd@biostar-pharma.com.

Reference
[1] 2025 ASCO Abstract #: 4040
[2] 2025 ASCO Abstract #: 3030
[3] B. Xu, T. Sun, Q. Zhang, et al. Annals of Oncology, 2021, 32(2): 218-228
[4] Pin Zhang, Tao Sun, Qingyuan Zhang, et al. Lancet Oncol 2017; 18: 371-83

FutureCeuticals Files Lawsuit Against NeuroRush Owner for Patent Infringement over Alleged Copycat Ingredient

MOMENCE, Ill., Sept. 15, 2025 /PRNewswire/ — VDF FutureCeuticals, Inc. filed a lawsuit against Aura Scientific, asserting that its brain performance ingredient NeuroRush – an extract of whole coffee fruit – infringes multiple of FutureCeuticals’ patents covering technology relating to coffee fruit, including patents relating to the use of coffee fruit compositions to improve measures of cognitive performance. The lawsuit seeks monetary damages, a finding of willful infringement, and the complete cessation of sales of the infringing ingredient.

FutureCeuticals created the whole coffee fruit market segment and has owned patents covering extracts of whole coffee fruit for many years. Among its coffee fruit technology are patents related to coffee fruit compositions for brain performance discovered following multiple human clinical trials FutureCeuticals commissioned and then published.

“Aura Scientific’s ingredient NeuroRush offers nothing new, simply ‘piggybacking’ on FutureCeuticals’ renowned, robust science, and patented discoveries in the coffee fruit sector, with infringement as the clear consequence. Indeed, this is among the most open and willful infringements we’ve ever seen, harming not only us, but our many licensees currently selling products containing our genuine ingredients, CognatiQ® and NeuroFactor®,” J. Randal Wexler, FutureCeuticals’ Vice President & General Counsel shared.

Although FutureCeuticals’ lawsuit seeks to stop this infringement at its source with Aura Scientific, FutureCeuticals is committed to doing everything necessary to rid the market entirely of the infringing ingredient. Mr. Wexler continued, “At this point, we are left with no other option than to vigorously protect and defend our IP rights and the interests of our customers in court, to the fullest extent of the law.”

FutureCeuticals noted that several dietary supplement consumer brands, both large and small, have recently launched brands containing Aura Scientific’s NeuroRush in their formulations. Mr. Wexler concluded, “We encourage product manufacturers to carefully evaluate their decision to include the NeuroRush material in their products in light of FutureCeuticals’ clear IP rights. We take our obligations to protect our IP on behalf of ourselves and our customers very seriously.”

About VDF FutureCeuticals, Inc.
VDF FutureCeuticals, Inc. is a leader in the research, development, and manufacture of fruit, vegetable, and grain-based powders and extracts for the functional food, beverage, and dietary supplement markets. We unlock the synergistic power of plants through the discovery and research of innovative and nutritious plant-based ingredients. CognatiQ® and NeuroFactor® are available exclusively from FutureCeuticals.